KP Tissue Inc. (TSE:KPT)’s quarterly earnings will be revealed on March, 14., Faxor reports. Last year’s EPS was $-0.46, while now analysts expect change of 113.04 % up from current $0.06 EPS. T_KPT’s profit could be $568,470 if the current EPS of $0.06 is accurate. Last quarter $-0.09 EPS was reported. Analysts sees -166.67 % EPS growth this quarter. The stock increased 3.98% or $0.36 during the last trading session, reaching $9.41.Currently KP Tissue Inc. is after 0.00% change in last March 6, 2018. KPT has 1,000 shares volume. KPT underperformed the S&P 500 by 4.37%.
KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in North America.The company has $89.16 million market cap. The firm operates through three divisions: Consumer Products, Away-From-Home, and Other.Last it reported negative earnings. It offers bathroom and facial tissues, paper towels, and paper towels and napkins, as well as disposable wiping products and washroom dispensing systems.
For more KP Tissue Inc. (TSE:KPT) news released recently go to: Theglobeandmail.com, Investingnews.com, Theglobeandmail.com, Theglobeandmail.com or Theglobeandmail.com. The titles are as follows: “Wednesday’s TSX breakouts: A stock with strong earnings growth ahead and 15 buy calls – The Globe and Mail” released on January 16, 2019, “Pharma Outlook 2019: Drug Pricing Dialogue Continues | INN – Investing News Network” on December 24, 2018, “Tuesday’s TSX breakouts: A stock with a stable dividend, a 22% gain expected and 9 buy calls – The Globe and Mail” with a publish date: January 15, 2019, “Thursday’s TSX breakouts: A growth stock reporting record results received a takeover offer last year – The Globe and Mail” and the last “Tuesday’s TSX breakouts: The next marijuana stock to potentially hit the $1-billion market cap level – The Globe and Mail” with publication date: May 15, 2018.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.